Delivery Order SPE2DB24D2101-SPE2DB24FKFGN
Award Date
7/17/24
Potential Completion Date
8/7/24
Potential Value
$8.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,718.02 firm fixed price delivery order is for RITUXAN HYCELA 1,400 MG-23,400 11.7ML, with a period of performance through July 25, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,664.56, is for the delivery of Rituxan Hycela, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $3,718.02, is for the delivery of Rituxan Hycela 1,400 mg-23,400 11.7 ml. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of May 21, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 1,600 mg-26,800 13.4 ml RITUXAN HYCELA pharmaceuticals. The contract has a completion date of March 12, 2024 and a potential value of $4,167.13. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger...
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,738.40 delivery order is for the specialty drug Rituxan Hycela 1,400 mg-23,400 11.7 ML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., which enables efficient procurement of a wide range of pharmaceutical products and medical...
This federal contract award (SPE2DB20D3103|SPE2DB22FM4X7) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,400 mg-23,400 11.7 ml units of the drug Rituxan Hycela. The contract has a ceiling value of $11,738.44 and was awarded on a firm fixed-price basis, with a completion date of February 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug Rituxan Hycela, with a ceiling value of $74,092.00 and a completion date of June 7, 2023. The contract was awarded on May 16, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,892.20 firm fixed-price delivery order covers the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a specialized pharmaceutical product. The contract has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,174.08 firm fixed-price delivery order is for the supply of RUXIENCE 100 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award, valued at $8,029.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is a firm fixed price delivery order for the supply of RUXIENCE 500 mg/50 ml vial, a specialty pharmaceutical product, in support of military treatment programs and facilities. The award has a period of performance through March 19, 2024. AmerisourceBergen...